XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Income Statements - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jan. 01, 2022
Jan. 02, 2021
Dec. 28, 2019
Revenue:      
Total revenue $ 2,988,244 $ 2,682,891 $ 2,336,319
Costs and expenses:      
Marketing and sales 560,262 516,460 481,673
Research and development 1,134,277 1,033,732 935,938
General and administrative 189,018 154,425 139,806
Amortization of acquired intangibles 19,640 18,009 12,128
Restructuring (1,048) 9,215 8,621
Total costs and expenses 2,209,155 2,037,339 1,844,523
Income from operations 779,089 645,552 491,796
Interest expense (16,980) (20,749) (18,829)
Other income, net 6,326 7,945 6,001
Income before provision (benefit) for income taxes 768,435 632,748 478,968
Provision (benefit) for income taxes 72,480 42,104 (510,011)
Net income $ 695,955 $ 590,644 $ 988,979
Net income per share - basic (in usd per share) $ 2.54 $ 2.16 $ 3.62
Net income per share - diluted (in usd per share) $ 2.50 $ 2.11 $ 3.53
Weighted average common shares outstanding - basic (shares) 273,504 273,728 273,239
Weighted average common shares outstanding - diluted (shares) 278,858 279,641 280,515
Product and maintenance      
Revenue:      
Total revenue $ 2,812,947 $ 2,536,617 $ 2,204,615
Costs and expenses:      
Cost of sales 222,647 231,026 189,146
Services      
Revenue:      
Total revenue 175,297 146,274 131,704
Costs and expenses:      
Cost of sales $ 84,359 $ 74,472 $ 77,211